Soligenix, Inc. (SNGX) Financials
SNGX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 9.8 million | 7.3 million |
| 2023-09-30 | 11.3 million | 7.1 million |
| 2023-06-30 | 13.8 million | 8.0 million |
| 2023-03-31 | 11.1 million | 14.5 million |
SNGX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.8 million | 141106 |
| 2023-09-30 | -2.7 million | 65400 |
| 2023-06-30 | -1.9 million | 90042 |
| 2023-03-31 | -2.2 million | 73634 |
SNGX Net Income
No data available :(
SNGX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 8.4 million | - | 233627 |
| 2023-09-30 | 10.3 million | - | 262117 |
| 2023-06-30 | 13.2 million | - | 289504 |
| 2023-03-31 | 10.3 million | - | 316319 |
SNGX Shares Outstanding
SNGX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 775944 | 1.4 million | - |
| 2023-09-30 | - | 826015 | 973040 | - |
| 2023-06-30 | - | 762699 | 890533 | - |
| 2023-03-31 | - | 946451 | 1.2 million | - |
SNGX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 244812 | 223136 |
| 2023-09-30 | 130440 | 110441 |
| 2023-06-30 | 206929 | 184021 |
| 2023-03-31 | 257178 | 226040 |
SNGX
Price: $0.42
52 week price:
Earnings Per Share: -0.79 USD
P/E Ratio: -0.44
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 16498
Ebitda: -951647Market Capitalization: 5.1 million